CIBOMA/2004-01/GEICAM 2003-11: Adjuvant Capecitabine Maintenance Therapy for Triple-Negative Early Breast Cancer


CIBOMA/2004-01/GEICAM 2003-11: Adjuvant Capecitabine Maintenance Therapy for Triple-Negative Early Breast Cancer
Slides from a presentation at SABCS 2010 and transcribed comments from recent interviews with William J Gradishar, MD (1/4/11) and Kathleen I Pritchard (12/30/10)

Lluch A et al. First safety data from a randomized Phase III (CIBOMA 2004-01/GEICAM 2003-11) trial assessing adjuvant capecitabine maintenance therapy after standard chemotherapy for triple-negative early breast cancer. San Antonio Breast Cancer Symposium 2010;Abstract P5-10-15.

Dr Gradishar is Director of Breast Medical Oncology at the Robert H Lurie Comprehensive Cancer Center and Professor of Medicine at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Dr Pritchard is Senior Scientist at Sunnybrook Research Institute, Medical Oncologist at Sunnybrook Odette Cancer Centre, Professor in the Department of Medicine and Faculty of Medicine at the University of Toronto in Toronto, Canada.